COMMUNIQUÉS West-GlobeNewswire

Paratek Pharmaceuticals Broadens Clinical Profile of NUZYRA™ (Omadacycline) with New ECCMID 2019 Data Presentations
15/04/2019
- New microbiology data reinforce activity of NUZYRA against broad range of pathogens commonly associated with community-acquired infections - Study supports no dose adjustments in patients based on BMI AMSTERDAM, The [...]
Proteon Therapeutics Announces Review of Potential Strategic Transactions
15/04/2019
WALTHAM, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular [...]
Globus Medical Launches FORTIFY Variable Angle Expandable Corpectomy Spacer System
15/04/2019
Continuing the Advancement in Spine Surgery with Expandable Technology Solutions AUDUBON, Pa., April 15, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today [...]
Intellia Therapeutics Announces Three Oral Presentations on In Vivo and Engineered Cell Therapy Data at the 22nd Annual Meeting of the American Society of Gene and Cell Therapy
15/04/2019
CAMBRIDGE, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), announced three oral presentations at the 22 nd Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), [...]
Sol-Gel Technologies Announces 50% Enrollment in Pivotal Phase III TWIN Program for the Treatment of Acne Vulgaris
15/04/2019
Patient enrollment of the pivotal Phase III TWIN clinical trials is on schedule Top-line results expected in the fourth quarter of 2019 NESS ZIONA, Israel, April 15, 2019 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. ( [...]
LHC Group Announces First Quarter 2019 Earnings Release and Conference Call Dates
15/04/2019
LAFAYETTE, La., April 15, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc . (NASDAQ: LHCG) today announced details for the release of its results for the first quarter ended March 31, 2019. LHC Group plans to issue its first [...]
Assure Holdings Reports Fourth Quarter and Full Year 2018 Financial Results
15/04/2019
2018 Managed Case Volume Increased 79% to 2,799, Expanded into Five States DENVER, April 15, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of [...]
Autolus Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares
15/04/2019
LONDON, April 15, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced the closing of its [...]
Solid Biosciences Announces Upcoming Preclinical Data Presentations at The American Society of Gene and Cell Therapy Annual Meeting
15/04/2019
CAMBRIDGE, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ:SLDB) today announced that preclinical data from its gene therapy program for Duchenne muscular dystrophy (DMD) will be presented at [...]
MSI Methylation Sciences, Inc. (MSI) Update on Recent BC Supreme Court Order for Quark Venture Inc. (Quark) to Pay MSI $20 million USD
15/04/2019
VANCOUVER, B.C., April 15, 2019 (GLOBE NEWSWIRE) -- On March 27 th , 2019, the British Columbia Supreme Court issued a judgement granting MSI leave to enforce its $20M USD Arbitration Award (plus interest and costs) [...]
CV Sciences, Inc. Appoints Deloitte & Touche LLP as Auditor
15/04/2019
LAS VEGAS, April 15, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB: CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products, announced that it has [...]
Amedisys Announces First Quarter Earnings Release and Conference Call Date
15/04/2019
BATON ROUGE, La., April 15, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), announced today that it will report results for the first quarter ended March 31, 2019, after the market closes on April 30, 2019. The [...]
Abeona Therapeutics to Present Data for ABO-401 in Cystic Fibrosis and Retinal Disorders at the American Society of Gene and Cell Therapy Annual Meeting
15/04/2019
New IND-enabling data for ABO-202 in CLN1 disease also to be highlighted NEW YORK and CLEVELAND, April 15, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell [...]
Akorn to Report First Quarter 2019 Financial Results and Host Conference Call
15/04/2019
LAKE FOREST, Ill., April 15, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release before market open on Tuesday [...]
In Personalized Medicine Feasibility Study, Stanford Medical Center, With Partners Notable and Tempus, Able to Make Rapid Personalized Treatment Recommendations for 100 Percent of Blood Cancer Patients
15/04/2019
SAN FRANCISCO, April 15, 2019 (GLOBE NEWSWIRE) -- Notable , which is redefining cancer treatment with a clinically validated AI platform that rapidly advances cancer drug development at a fraction of traditional costs, [...]
Eloxx Pharmaceuticals to Participate in the 2019 5th Annual SunTrust Robinson Humphrey (STRH) Life Sciences Summit on May 7, 2019
15/04/2019
WALTHAM, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic [...]
Addus HomeCare Announces First-Quarter 2019 Earnings Release and Conference Call
15/04/2019
Frisco, Texas, April 15, 2019 (GLOBE NEWSWIRE) -- Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the first quarter ended March 31, 2019, on [...]
Grant of warrants
15/04/2019
April 15, 2019 Announcement no. 5 Grant of warrants Today, and in accordance with the company's Remuneration policy and guidelines for incentive-based remuneration and the authorization in section 18 of the Articles of [...]
Homology Medicines Announces Upcoming Presentations on its Gene Therapy and Gene Editing Platform and Manufacturing Capabilities at the American Society of Gene & Cell Therapy Meeting
15/04/2019
BEDFORD, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today upcoming presentations highlighting its gene therapy and gene editing platform, [...]

Pages